You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SVR35

Showing 1 - 25 of 276
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis Trial in China (TQ05105 Tablets, TQB3617 Capsules)

Not yet recruiting
  • Myelofibrosis
  • TQ05105 Tablets
  • TQB3617 Capsules
  • Guangzhou, Guangdong, China
  • +19 more
Nov 7, 2023

Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)

Not yet recruiting
  • Myelofibrosis
  • Moderate Thrombocytopenia
  • (no location specified)
Jul 31, 2023

Myelofibrosis Trial in Worldwide (Selinexor, Physician's Choice Treatment)

Recruiting
  • Myelofibrosis
  • Los Angeles, California
  • +41 more
Jan 30, 2023

Myelofibrosis Trial in United States (Selinexor, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Duarte, California
  • +4 more
Jan 30, 2023

Moderate and High Risk Myelofibrosis Trial in China (TQ05105 tablets, Hydroxycarbamide tablets)

Recruiting
  • Moderate and High Risk Myelofibrosis
  • TQ05105 tablets
  • Hydroxycarbamide tablets
  • Beijing, Beijing, China
  • +3 more
Nov 23, 2021

Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +13 more
Jan 10, 2023

Myeloproliferative Tumors Trial in Worldwide (INCA033989, Ruxolitinib)

Recruiting
  • Myeloproliferative Neoplasms
  • Herston, Queensland, Australia
  • +22 more
Jun 30, 2023

HCV Trial in Cairo (Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets)

Recruiting
  • HCV
  • Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets
  • Cairo, Egypt
    Faculty of Medicine, Ain-Shams University Research Institute-Cli
May 2, 2023

Myelofibrosis (MF) Trial in Worldwide (Navitoclax, Ruxolitinib, Best Available Therapy (BAT))

Recruiting
  • Myelofibrosis (MF)
  • Chandler, Arizona
  • +207 more
Jul 26, 2022

Myelofibrosis (MF) Trial in Korea, Republic of, South Africa, United States (Mivebresib, Navitoclax, Ruxolitinib)

Active, not recruiting
  • Myelofibrosis (MF)
  • Stony Brook, New York
  • +6 more
Mar 23, 2022

Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF) Trial in

Recruiting
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Birmingham, Alabama
  • +155 more
Aug 12, 2022

Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV-MF), Post-Essential Thrombocythemia Myelofibrosis

Recruiting
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Glendale, California
  • +28 more
May 5, 2022

Primary Myelofibrosis Trial in Japan (Fedratinib)

Recruiting
  • Primary Myelofibrosis
  • Suwa, Nagano, Japan
  • +25 more
Jan 18, 2023

Myelofibrosis Trial in Worldwide (BMS-986158, Ruxolitinib, Fedratinib)

Recruiting
  • Myelofibrosis
  • La Jolla, California
  • +36 more
Jan 13, 2023

Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
  • Phoenix, Arizona
  • +47 more
Jun 27, 2022

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Birmingham, Alabama
  • +151 more
Aug 22, 2022

Chronic Hepatitis C Trial in United States (SOF/LDV (sofosbuvir/ledipasvir), PrOD (ombitasvir/paritaprevir/ritonavir with

Completed
Has Results
  • Chronic Hepatitis C
  • SOF/LDV (sofosbuvir/ledipasvir)
  • +3 more
  • Little Rock, Arkansas
  • +37 more
Dec 1, 2021

Atopic Dermatitis Trial (Topialyse Baume Barrière)

Withdrawn
  • Atopic Dermatitis
  • Topialyse Baume Barrière
  • (no location specified)
Oct 6, 2022

Myelofibrosis Trial in Hong Kong (Bomedemstat)

Recruiting
  • Myelofibrosis
  • Hong Kong, Hong Kong
    Department of Medicine, the University of Hong Kong, Queen Mary
Oct 3, 2022

Hepatitis C Infection, Hepatitis C Virus Trial (ombitasvir/paritaprevir/ritonavir, dasabuvir)

Completed
Has Results
  • Hepatitis C Infection
  • Hepatitis C Virus
  • (no location specified)
Jul 28, 2021

Hypotension, Hip Fractures, Anesthesia Trial (Norepinephrine 1 MG/ML)

Not yet recruiting
  • Hypotension
  • +2 more
  • Norepinephrine 1 MG/ML
  • (no location specified)
Oct 4, 2022

Hepatitis C Trial in Worldwide (SOF/VEL for 6 weeks, SOF/VEL for 12 weeks)

Completed
Has Results
  • Hepatitis C
  • SOF/VEL for 6 weeks
  • SOF/VEL for 12 weeks
  • Baltimore, Maryland
  • +24 more
Nov 22, 2021

Hepatitis C Infection, HIV Infection Trial in Washington, Bethesda (Nitazoxanide With Pegylated Interferon And Ribavirin)

Completed
Has Results
  • Hepatitis C Infection
  • HIV Infection
  • Nitazoxanide With Pegylated Interferon And Ribavirin
  • Washington, District of Columbia
  • +3 more
Sep 14, 2021

HIV, Hepatitis C Trial in Puerto Rico, United States (Pegylated-Interferon Alfa 2b (PEG-IFN), Ribavirin (RBV), Boceprevir (BOC))

Completed
Has Results
  • HIV Infections
  • Hepatitis C
  • Pegylated-Interferon Alfa 2b (PEG-IFN)
  • +2 more
  • Birmingham, Alabama
  • +42 more
Nov 2, 2021

Transesophageal Echocardiography, Acute Respiratory Distress Syndrome, Right Ventricular Dysfunction Trial in Wuhan

Not yet recruiting
  • Transesophageal Echocardiography
  • +2 more
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Mar 12, 2023